SRTS / Learning Lessons From 3 Stocks Flourishing In A Desperate Biotech Bear Market

Sensus Healthcare, Inc (NASDAQ:SRTS ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Kim Golodetz - IR Joseph Sardano more_horizontal

Sensus Healthcare, Inc. (SRTS) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares more_horizontal

The agreement includes the distribution of Sensus Healthcare's (SRTS) SRT-100, SRT-100+ and SR-100 Vision systems, specifically designed for the treat more_horizontal

Sensus Healthcare, Inc. (SRTS) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of $0.11. This compares to earnin more_horizontal

While the adage that you get what you pay for generally rings true, you can sometimes cheat up this narrative with the best stocks to buy under $10. W more_horizontal

While unproven biotechnology firms almost always carry significant risks, small-cap biotech stocks in particular typically impose jaw-dropping volatil more_horizontal

If you aspire to one day topple entrepreneurial genius Elon Musk on the net wealth rankings through the equities market exclusively, you're obviously more_horizontal

Sensus Healthcare quickly fell 30% after a slight miss on Q4 revenue and earnings. Actual numbers were a slight beat and only appeared to be a miss, t more_horizontal